MYCN and neoplasm: The results obtained from both cohorts are very similar and clearly show that high expression of CCDC86 is found in patients with MYCN amplifications (Fig. 5B,D) and the expression level of CCDC86 positively correlates with tumour stage progression and malignancy (Fig. 5C,E).